Sunil Healthcare Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Friday, May 29, 2026. The meeting will be conducted through video conferencing/audio visual connection, with the deemed venue being the company's registered office at 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049.

Board Meeting to Consider Audited Financial Results

The board meeting has been convened pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The primary agenda of the meeting is to consider, approve, and take on record the audited financial results of the company for the period detailed below.

Trading Window Closure

In accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has confirmed that the Trading Window remains closed. This closure was previously intimated to the exchanges vide the company's letter dated March 27, 2026.

The intimation was signed by Satyendu Pattnaik, Company Secretary & Compliance Officer (M.No. F7736), on behalf of Sunil Healthcare Limited, and was dated May 19, 2026.

Sunil Healthcare Limited has submitted its mandatory compliance certificate under Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended March 31, 2026. The certificate demonstrates the company's adherence to regulatory requirements regarding share transfer processes and timelines.

Regulatory Submission Details

The compliance certificate was filed on April 16, 2026, and submitted to both The Bombay Stock Exchange Limited and The Calcutta Stock Exchange Ltd. Company Secretary and Compliance Officer Satyendu Patnaik (F-7736) signed and submitted the documentation on behalf of Sunil Healthcare Limited.

Compliance Verification Process

ATCS & Associates Practicing Company Secretaries conducted the compliance verification for the reporting period. The firm, headed by FCS Tara Chand Sharma (Partner, FCS No.: 5749, CP No.: 4078), examined all relevant documentation maintained by the company's Registrar & Transfer Agent.

Verification Scope

The compliance verification covered comprehensive examination of:

• Share Transfer Deeds
• Memorandum of Transfers
• Company registers and files
• Documentation maintained by Alankit Assignments Limited (RTA)

Compliance Certification

The practicing company secretary certified that Sunil Healthcare Limited has delivered share certificates relating to transfers received during the financial year 2025-26 within the prescribed timeline of fifteen days from the date of lodgment. This compliance extends to various share-related processes including transfer, sub-division, consolidation, renewal, exchange, and endorsement of calls/allotment monies.

The certificate confirms that all share certificates were issued within the regulatory timeframe, except for those rejected on technical grounds. This submission fulfills the company's obligation under SEBI LODR regulations and demonstrates its commitment to maintaining proper share transfer procedures and regulatory compliance.